Jaffe Food Allergy Institute
New York, 10029, United States
NCT Number: NCT02417493
The purpose of the present study is to determine if asking adolescent patients (ages 13-17) to self-inject an empty syringe into their thigh during routine clinic visits results in increased reported comfort with self-injection, reduced anxiety regarding self-injection and food allergy management for both patient and caregiver(s), and in greater perceived likelihood of epinephrine self-injection, in the event of an emergency.
Looking for future studies?
Notify Me13 year–17 year
All sexes
Interventional
Not applicable
New York, 10029, United States
The purpose of the present study is to determine if asking adolescent patients (ages 13-17) to self-inject an empty syringe into their thigh during routine clinic visits results in increased reported comfort with self-injection, reduced anxiety regarding self-injection and food allergy management for both patient and caregiver(s), and in greater perceived likelihood of epinephrine self-injection, in the event of an emergency. Forty participants, in total, will be recruited during routine visits to an outpatient allergy clinic. Half of all participants will be randomized to the behavioral self-management intervention; whereby patients will insert a needle attached to an empty syringe into their thigh (simulating an injection of epinephrine); the other half of participants will be randomized to the control condition, and will be encouraged to speak to their physician about self-injection, but will not undergo the self-injection protocol. Prior to randomization, baseline measures will be collected on patient's comfort with epinephrine self-injection. Following the self-injection protocol and/or the discussion of self-injection with the physician, all participants will complete immediate post-intervention questionnaires at clinic about comfort with self-injection, health care management and anxiety. One month following the clinic visit, all patients will be sent a follow-up questionnaire that will include items identical to the ones completed at immediate post-intervention.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 1
Immediate pre-post differences within the intervention group in the score obtained on a child-reported "comfort with self-injection" questionnaire.
Time frame: Day 1
Immediate pre-post differences within the intervention group in the score obtained on a child-reported likelihood of self-injection questionnaire.
Time frame: Day 1
Immediate pre-post differences within the intervention group in the score obtained on a parent-reported "child's comfort with self-injection" questionnaire.
Time frame: 1 month post-intervention
Immediate post-1 month post differences between groups in the score obtained on a child-reported "comfort with self-injection" questionnaire.
Time frame: 1 month post-intervention
Immediate post- 1 month post differences between groups in the score obtained on a parent-reported "child's comfort with self-injection" questionnaire.
Icahn School of Medicine at Mount Sinai
Other
Epinephrine Self-injection and Self-management of Food Allergies
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03679676
Food Allergy, Food Hypersensitivity
Los Angeles, California, United States
View Trial DetailsNCT06273605
Food Allergy, Food Allergy in Infants
Melbourne, Victoria, Australia
View Trial DetailsNCT07210320
Anaphylaxis, Food Allergy
St Louis, Missouri, United States
View Trial DetailsNCT03181009
Food Allergy, Food Hypersensitivity
Los Angeles, California, United States
View Trial Details